STOCK TITAN

Carter Bankshares (CARE) CEO awarded 12,300 restricted shares in new equity grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Van Dyke Litz H reported acquisition or exercise transactions in this Form 4 filing.

Carter Bankshares, Inc. reported that Chief Executive Officer Van Dyke Litz received a grant of 12,300 shares of Common Stock as a restricted stock award. The award carries three-year vesting, with one-third vesting each year. Following this grant, his direct holdings total 79,767 shares of Common Stock.

Positive

  • None.

Negative

  • None.
Insider Van Dyke Litz H
Role CHIEF EXECUTIVE OFFICER
Type Security Shares Price Value
Grant/Award Common Stock 12,300 $0.00 --
Holdings After Transaction: Common Stock — 79,767 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Restricted shares granted 12,300 shares Common Stock award to CEO Van Dyke Litz
Grant price per share $0.00 per share Restricted stock award compensation, not open-market purchase
Shares held after grant 79,767 shares CEO direct ownership following the reported transaction
Vesting schedule 3 years (1/3 each year) Restricted Stock Award vesting terms per footnote
Restricted Stock Award financial
"Restricted Stock Award - 3 year vesting (1/3 each year)"
A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.
vesting financial
"3 year vesting (1/3 each year)"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Form 4 regulatory
"This Form 4 reports only a grant-type acquisition of 12,300 restricted shares."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
executive compensation financial
"The grant reflects equity-based executive compensation rather than an open-market transaction."
Payments and benefits given to a company's top leaders — including base salary, cash bonuses, stock awards, options and retirement or perquisites — designed to compensate and motivate them. Investors care because these packages affect a company’s costs, influence executives’ decisions and signal how well management’s interests line up with shareholders’; like a captain’s contract, the structure of pay can encourage safe navigation toward long-term gains or risky short-term moves that hurt returns.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Van Dyke Litz H

(Last)(First)(Middle)
1300 KINGS MOUNTAIN RD.

(Street)
MARTINSVILLE VIRGINIA 24112

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Carter Bankshares, Inc. [ CARE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
CHIEF EXECUTIVE OFFICER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/30/2026A12,300(1)A$079,767D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted Stock Award - 3 year vesting (1/3 each year)
Remarks:
/s/ Lisa J. Correll, Attorney-in-fact07/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CARE CEO Van Dyke Litz report?

Van Dyke Litz reported receiving 12,300 shares of Carter Bankshares Common Stock as a restricted stock award. The grant was recorded at no cash price per share and represents equity-based compensation rather than an open-market purchase or sale.

How many CARE shares does the CEO hold after this Form 4 filing?

After the restricted stock award, Van Dyke Litz directly holds 79,767 shares of Carter Bankshares Common Stock. This figure includes the newly granted 12,300 restricted shares, which are subject to the specified three-year vesting schedule.

Was the CARE CEO’s Form 4 transaction a stock purchase or a grant?

The transaction was a grant, not a market purchase. Van Dyke Litz received 12,300 shares at a reported price of $0.00 per share as a restricted stock award, reflecting compensation rather than buying shares on the open market.

What are the vesting terms of the CARE CEO’s restricted stock award?

The restricted stock award vests over three years, with one-third of the 12,300-share grant vesting each year. This schedule ties the CEO’s compensation to continued service and long-term alignment with Carter Bankshares’ shareholders.

Does the CARE Form 4 show any stock sales by the CEO?

The Form 4 shows no stock sales by Van Dyke Litz. It reports only a grant-type acquisition of 12,300 restricted shares and indicates no sell transactions or dispositions in this particular filing.